EverSource Wealth Advisors LLC increased its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 79.8% during the 4th quarter, Holdings Channel reports. The institutional investor owned ...
Hologic's Surgical business has been driving strong broad-based performance by expanding access to technologies in new global ...
Hologic's Surgical business has been driving strong broad-based performance by expanding access to technologies in new global ...
Hologic HOLX stock has been experiencing a declining trend as it navigates an evolving geopolitical and macroeconomic landscape. The shares of the Marlborough, MA-based women’s health company have ...
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
US stocks finished with steep losses on Tuesday as the selling pressure resumed after a brief two-day rebound, with blue chip tech names leading the decline.
Hologic (HOLX) closed at $61.82 in the latest trading session, marking a +1.83% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.64%. Meanwhile, the Dow ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...